Senseonics Holdings, Inc. (SENS) analyst actions
Rating and price-target actions on SENS in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the SENS overview →
1 measured SENS analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Senseonics Initiates First-in-Human Study of Freedom, Designed to be the World’s First CGM System with No On-body Component | Press release | -0.33% | -1.06% |
Keep exploring
More SENS: earnings → · SEC filings → · SENS overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | 318 | -0.89% | 34% |
| MATEON THERAPEUTICS (MATN) | 318 | 0.00% | 35% |
| Allogene Therapeutics, Inc. (ALLO) | 316 | +0.18% | 51% |
| Denali Therapeutics Inc. (DNLI) | 316 | +0.07% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.